Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients (Q58614888)
Jump to navigation
Jump to search
article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase III Trial of Capecitabine Plus Oxaliplatin As Adjuvant Therapy for Stage III Colon Cancer: A Planned Safety Analysis in 1,864 Patients |
article |
Statements
Phase III trial of capecitabine plus oxaliplatin as adjuvant therapy for stage III colon cancer: a planned safety analysis in 1,864 patients (English)
Hans-Joachim Schmoll
Thomas Cartwright
Arie Figer
Jean Maroun
Robert Lim
Eric Van Cutsem
Young-Suk Park
Joseph McKendrick
Claire Topham
Gemma Soler-Gonzalez
Mark Hill
Florin Sirzén
Marek P Nowacki
Daniel G Haller